Effectiveness of COVID-19 Pfizer-BioNTech BNT162b2 mRNA Vaccination in Preventing COVID-19–Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Nonimmunocompromised Children and Adolescents Aged 5–1 – cdc.gov

1. Effectiveness of COVID-19 Pfizer-BioNTech BNT162b2 mRNA Vaccination in Preventing COVID-19–Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Nonimmunocompromised Children and Adolescents Aged 5–1  cdc.gov
2. Here’s how kids’ COVID vaccines are holding up in the real world amid omicron  Ars Technica
3. Why Can’t Kids Just Get Bigger Doses Of The COVID Vaccine?  HuffPost
4. This Week in COVID & Education Policy: Vaccines Offering Poorer Protection for 5- to 11-Year-Olds, the Scope of Classroom Disruptions in 2022 and More Key Updates  The 74
5. Third vaccine dose boosts Omicron protection, with some waning  CIDRAP
6. View Full Coverage on Google News

Source: Weather